• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间日疟原虫疟疾的常规治疗无法使奎宁在血液中达到足够的浓度。

Consensual treatment of plasmodium falciparum malaria does not lead to adequate quinine blood concentrations.

作者信息

Roger P-M, Marty P, Prestifilippo L, Garaffo R, Hyvernat H, Dunais B, Chaillou S, Delaunay P, Bernardin G, Mattéi M, Le Fichoux Y, Dellamonica P

机构信息

Service des Maladies Infectieuses et Tropicales, Hôpital de l'Archet, Centre Hospitalier Universitaire, Nice, France.

出版信息

J Infect. 2002 Oct;45(3):160-4. doi: 10.1016/s0163-4453(02)91246-6.

DOI:10.1016/s0163-4453(02)91246-6
PMID:12387771
Abstract

Since 1996, we have a common protocol in the Infectious Diseases Department and the Intensive Care Unit for the administration of quinine in case of Plasmodium falciparum malaria. Patients were classified as uncomplicated form of malaria (UFM) or severe form of malaria (SFM) according to WHO criteria, adding parasitemia >5% as a criteria of SFM. Treatment of SFM should consist of a 4 h infusion of 16 mg/kg quinine-base loading dose, followed by 8 mg/kg every 8 h. Patients with UFM receive quinine-base, 8 mg/kg every 8 h. A therapeutic index of 10-15 mg/l was considered adequate. Hypoglycemia and cardiotoxicity were the two main adverse effects of quinine to be investigated. In order to verify that these modalities for quinine administration are associated with adequate quinine blood concentrations, we have reviewed the pharmacological data and the occurrence of adverse effects. Between April 1996 and December 2000, 95 patients were hospitalised: 25 with SFM and 70 with UFM: 78/95 patients (82%) received adequate treatment and 26/95 (28%) of the patients presented an overdosage of quinine. Six severe adverse effects were observed, even in case of adequate quinine administration. Consensual treatment of malaria does not confer adequate quinine blood concentrations, and toxic effects are still common.

摘要

自1996年以来,我们传染病科和重症监护病房针对恶性疟原虫疟疾制定了使用奎宁的通用方案。根据世界卫生组织标准,将患者分为非重症疟疾(UFM)或重症疟疾(SFM),将寄生虫血症>5%作为SFM的一项标准。SFM的治疗应包括静脉输注16mg/kg奎宁碱负荷剂量,持续4小时,随后每8小时输注8mg/kg。UFM患者每8小时接受8mg/kg奎宁碱治疗。治疗指数为10-15mg/l被认为是足够的。低血糖和心脏毒性是要研究的奎宁的两种主要不良反应。为了验证这些奎宁给药方式是否与足够的奎宁血药浓度相关,我们回顾了药理学数据和不良反应的发生情况。在1996年4月至2000年12月期间,95例患者住院治疗:25例为SFM,70例为UFM;95例患者中有78例(82%)接受了充分治疗,26例(28%)患者出现奎宁过量。即使在奎宁给药充分的情况下,也观察到6例严重不良反应。疟疾的共识性治疗并未带来足够的奎宁血药浓度,且毒性作用仍然常见。

相似文献

1
Consensual treatment of plasmodium falciparum malaria does not lead to adequate quinine blood concentrations.间日疟原虫疟疾的常规治疗无法使奎宁在血液中达到足够的浓度。
J Infect. 2002 Oct;45(3):160-4. doi: 10.1016/s0163-4453(02)91246-6.
2
Quinine levels revisited: the value of routine drug level monitoring for those on parenteral therapy.重新审视奎宁水平:对于接受肠外治疗的患者进行常规药物水平监测的价值。
Acta Trop. 2006 Feb;97(2):233-7. doi: 10.1016/j.actatropica.2005.11.006. Epub 2006 Jan 4.
3
Early treatment failure in severe malaria resulting from abnormally low plasma quinine concentrations.因血浆奎宁浓度异常低导致的重症疟疾早期治疗失败。
Trans R Soc Trop Med Hyg. 2006 Feb;100(2):184-6. doi: 10.1016/j.trstmh.2005.01.008. Epub 2005 Nov 10.
4
Taste-masked quinine pamoate tablets for treatment of children with uncomplicated Plasmodium falciparum malaria.掩味奎宁棕榈酸酯片治疗儿童无并发症恶性疟原虫疟疾。
Int J Pharm. 2010 Jun 15;392(1-2):29-34. doi: 10.1016/j.ijpharm.2010.03.023. Epub 2010 Mar 15.
5
Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria.一种新型直肠用奎宁制剂治疗儿童恶性疟原虫疟疾的疗效及药代动力学
Br J Clin Pharmacol. 1996 May;41(5):389-95. doi: 10.1046/j.1365-2125.1996.03246.x.
6
Taste-masked quinine sulphate pellets: bio-availability in adults and steady-state plasma concentrations in children with uncomplicated Plasmodium falciparum malaria.包衣硫酸奎宁微丸:成人中的生物利用度及单纯性恶性疟原虫疟疾患儿的稳态血药浓度
Ann Trop Paediatr. 2008 Jun;28(2):103-9. doi: 10.1179/146532808X302116.
7
Population pharmacokinetic and pharmacodynamic properties of intramuscular quinine in Tanzanian children with severe Falciparum malaria.坦桑尼亚重症恶性疟儿童肌内奎宁的群体药代动力学和药效学特征。
Antimicrob Agents Chemother. 2013 Feb;57(2):775-83. doi: 10.1128/AAC.01349-12. Epub 2012 Nov 26.
8
Relationship between plasma and red blood cell concentrations of quinine in Brazilian children with uncomplicated Plasmodium falciparum malaria on oral therapy.接受口服治疗的巴西单纯性恶性疟原虫疟疾患儿血浆和红细胞中奎宁浓度的关系
Rev Inst Med Trop Sao Paulo. 2009 Mar-Apr;51(2):109-10. doi: 10.1590/s0036-46652009000200009.
9
Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.青蒿琥酯口服制剂与奎宁加四环素治疗急性非复杂性恶性疟的比较。
Bull World Health Organ. 1994;72(2):233-8.
10
Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria.奎宁的药代动力学:健康白种人和恶性疟患者的耳毒性和心脏毒性作用
Trop Med Int Health. 1998 Jun;3(6):482-9. doi: 10.1046/j.1365-3156.1998.00252.x.